Stromal cell-derived factor-1 as a serologic biomarker for the diagnosis of colon ischemia with chronic cardiovascular disease
- PMID: 32502013
- PMCID: PMC7306348
- DOI: 10.1097/MD.0000000000020539
Stromal cell-derived factor-1 as a serologic biomarker for the diagnosis of colon ischemia with chronic cardiovascular disease
Abstract
Colon ischemia (CI) is the most common ischemic disorder of the gastrointestinal tract. Although some markers of CI, such as procalcitonin and alkaline phosphatase, have been reported, few specific serum markers have been identified. We investigated whether serum stromal cell-derived factor-1 (SDF-1) is a specific marker of CI and clarified the relationship between serum SDF-1 level and CI according to a history of combined chronic cardiovascular disease (CVD).We measured SDF-1 level and other serological markers in 84 patients (control, n = 20; CI without chronic CVD, n = 21; chronic CVD without CI, n = 20; CI with chronic CVD, n = 23).Patients with CI were older than those without CI. There were more women in the CI groups than those without CI. At admission, SDF-1 level was significantly higher in patients having CI with chronic CVD (P < .001) than in other groups. SDF-1 level was significantly higher at admission than at discharge in patients having CI with chronic CVD (P < .001) but not in patients having CI without chronic CVD. SDF-1 level did not differ according to symptoms, involved sites, or duration of hospitalization. At a cutoff value of 0.5 pg/mL for the SDF-1 level in patients having CI with chronic CVD, the sensitivity and specificity for SDF-1 were 91.3% and 95%, respectively. The area-under-the-curve (AUC) value was 0.95. In the logistic regression analysis, an elevation of the SDF-1 level to >0.5 pg/mL was a significant indicator of CI with chronic CVD [odds ratio (OR), 114.914; 95% confidence interval, 10.51 to >999.999; P < .001].SDF-1 could be a useful early biomarker for the diagnosis of CI in patients with chronic CVD.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures

Similar articles
-
Stromal cell-derived factor 1 as a biomarker of heart failure and mortality risk.Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2100-5. doi: 10.1161/ATVBAHA.114.303579. Epub 2014 Jul 24. Arterioscler Thromb Vasc Biol. 2014. PMID: 25060794 Free PMC article.
-
Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.Cytokine. 2015 May;73(1):16-22. doi: 10.1016/j.cyto.2015.01.010. Epub 2015 Feb 14. Cytokine. 2015. PMID: 25689618
-
Role of stromal cell-derived factor-1 in patients with non-ST elevation acute coronary syndrome.Int Heart J. 2014;55(3):219-27. doi: 10.1536/ihj.13-289. Epub 2014 May 7. Int Heart J. 2014. PMID: 24806379
-
Platelet expression of stromal-cell-derived factor-1 (SDF-1): an indicator for ACS?Int J Cardiol. 2013 Mar 20;164(1):111-5. doi: 10.1016/j.ijcard.2011.06.082. Epub 2011 Jul 6. Int J Cardiol. 2013. PMID: 21737155
-
Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.Eur J Gastroenterol Hepatol. 2019 May;31(5):555-562. doi: 10.1097/MEG.0000000000001353. Eur J Gastroenterol Hepatol. 2019. PMID: 30614883
Cited by
-
Diagnostic accuracy of biomarkers to detect acute mesenteric ischaemia in adult patients: a systematic review and meta-analysis.World J Emerg Surg. 2023 Sep 1;18(1):44. doi: 10.1186/s13017-023-00512-9. World J Emerg Surg. 2023. PMID: 37658356 Free PMC article.
-
Precision medicine in intestinal ischemia: the emerging role of biomarkers.Intern Emerg Med. 2025 Mar;20(2):369-379. doi: 10.1007/s11739-024-03808-z. Epub 2024 Nov 8. Intern Emerg Med. 2025. PMID: 39511053 Review.
-
Association of serum stromal cell-derived factor 1 levels with EZSCAN score and its derived indicators in patients with type 2 diabetes.Endocr Connect. 2022 Apr 26;11(4):e210629. doi: 10.1530/EC-21-0629. Endocr Connect. 2022. PMID: 35275092 Free PMC article.
References
-
- Brandt LJ, Boley SJ. Colonic ischemia. Surg Clin North Am 1992;72:203–29. - PubMed
-
- Flynn AD, Valentine JF. Update on the diagnosis and management of colon ischemia. Curr Treat Options Gastroenterol 2016;14:128–39. - PubMed
-
- Korotinski S, Katz A, Malnick SD. Chronic ischaemic bowel diseases in the aged: go with the flow. Age Ageing 2005;34:10–6. - PubMed
-
- Liberski SM, Koch KL, Atnip RG, et al. Ischemic gastroparesis: resolution after revascularization. Gastroenterology 1990;99:252–7. - PubMed
-
- Zou X, Cao J, Yao Y, et al. Endoscopic findings and clinicopathologic characteristics of ischemic colitis: a report of 85 cases. Dig Dis Sci 2009;54:2009–15. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources